$SOMX: Head of the Class
March 19th, 2010 at 9:25 am Posted by
The Dean is pleased to announce that the kid at the back of the room has just been promoted to the front row.
What’s that girl? Timmy was wide awake and read The Dean’s Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) alert on January 22nd when the stock was trading at just $2.91 per share?
If you’re following The Dean, you’d know that $SOMX made the Honor Roll yesterday and for a damn good reason—FDA approval of their new drug application (NDA) for Silenor, an insomnia treatment.
What’s even better about that news is the fact that $SOMX saw a new high of $10.01 yesterday, which means students could’ve made more than 240% on The Dean’s alert.
For those of you who stay up all night thinking about missing out on free stock picks like $SOMX, Silenor is the first and only prescription sleep aid to provide a full night’s sleep without abuse potential. On top of that, Standard & Poor’s raised their opinion of $SOMX on the heels of this news.
The Dean thinks $SOMX is a great company with terrific fundamentals and spectacular upside potential in a very profitable niche of the pharmaceutical industry. Further evidence of this is the company’s 1-year chart, which shows this NASDAQ stock moving from a low of $0.30 to yesterday’s high of $10.01—a difference of 3237%. That’s a lot of green!
But, don’t think for a minute that this stock is done. After a likely pullback over the next couple of days (sell the news still rules), The Dean thinks $SOMX is a solid buy with nothing but upside over the coming semesters.
With a market cap now in the $200 million range, this company is the new kid on the block and either a successful up-and-comer, or an obvious takeover candidate for big pharma. Compare $SOMX‘s product to Sanofi-Avenits’ (NYSE: SNY) Ambien CR, whose side effects are legendary, Silenor is expected to be a big winner for the treatment of insomnia.
The Dean’s recommendation: Dust yourself off for falling asleep at the wheel and missing out, follow $SOMX for a couple of days, and look to accumulate on dips.
